1. Candida glabrata maintains two HAP1 ohnologs, HAP1A and HAP1B , for distinct roles in ergosterol gene regulation to mediate sterol homeostasis under azole and hypoxic conditions.
- Author
-
Saha D, Gregor JB, Hoda S, Eastman KE, Gutierrez-Schultz VA, Navarrete M, Wisecaver JH, and Briggs SD
- Subjects
- Transcription Factors genetics, Transcription Factors metabolism, Saccharomyces cerevisiae genetics, Saccharomyces cerevisiae drug effects, Sterols metabolism, Candida glabrata genetics, Candida glabrata drug effects, Gene Expression Regulation, Fungal drug effects, Antifungal Agents pharmacology, Azoles pharmacology, Ergosterol metabolism, Fungal Proteins genetics, Fungal Proteins metabolism, Homeostasis, Drug Resistance, Fungal genetics
- Abstract
Candida glabrata exhibits innate resistance to azole antifungal drugs but also has the propensity to rapidly develop clinical drug resistance. Azole drugs, which target Erg11, is one of the major classes of antifungals used to treat Candida infections. Despite their widespread use, the mechanism controlling azole-induced ERG gene expression and drug resistance in C. glabrata has primarily revolved around Upc2 and/or Pdr1. Phylogenetic and syntenic analyses revealed that C. glabrata , following a whole genome duplication event, maintained HAP1A and HAP1B , whereas Saccharomyces cerevisiae only retained the HAP1A ortholog, HAP1 . In this study, we determined the function of two zinc cluster transcription factors, Hap1A and Hap1B, as direct regulators of ERG genes. In S. cerevisiae, Hap1, an ortholog of Hap1A, is a known transcription factor controlling ERG gene expression under aerobic and hypoxic conditions. Interestingly, deleting HAP1 or HAP1B in either S. cerevisiae or C. glabrata, respectively, showed altered susceptibility to azoles. In contrast, the strain deleted for HAP1A did not exhibit azole susceptibility. We also determined that the increased azole susceptibility in a hap1B Δ strain is attributed to decreased azole-induced expression of ERG genes, resulting in decreased levels of total ergosterol. Surprisingly, Hap1A protein expression is barely detected under aerobic conditions but is specifically induced under hypoxic conditions, where Hap1A is required for the repression of ERG genes. However, in the absence of Hap1A, Hap1B can compensate as a transcriptional repressor. Our study shows that Hap1A and Hap1B is utilized by C. glabrata to adapt to specific host and environmental conditions., Importance: Invasive and drug-resistant fungal infections pose a significant public health concern. Candida glabrata , a human fungal pathogen, is often difficult to treat due to its intrinsic resistance to azole antifungal drugs and its capacity to develop clinical drug resistance. Therefore, understanding the pathways that facilitate fungal growth and environmental adaptation may lead to novel drug targets and/or more efficacious antifungal therapies. While the mechanisms of azole resistance in Candida species have been extensively studied, the roles of zinc cluster transcription factors, such as Hap1A and Hap1B, in C. glabrata have remained largely unexplored until now. Our research shows that these factors play distinct yet crucial roles in regulating ergosterol homeostasis under azole drug treatment and oxygen-limiting growth conditions. These findings offer new insights into how this pathogen adapts to different environmental conditions and enhances our understanding of factors that alter drug susceptibility and/or resistance., Competing Interests: The authors declare no conflict of interest.
- Published
- 2024
- Full Text
- View/download PDF